Human prolactin antagonist-angiogenesis inhibitor fusion proteins

• 收藏
• 分享

专利权人:

Wen Y. Chen

发明人:

Wen Y. Chen

申请号：

US12010395

公开号：

US08304381B2

申请日:

2008.01.24

申请国别(地区):

US

年份:

2012

代理人:

摘要：

A novel fusion protein, comprising a receptor-antagonizing domain and an angiogenesis inhibiting domain, characterized, for example, by its ability to block apoptosis and/or inhibit endocrine response, is useful in treating cancer. For example, a human prolactin antagonist-endostatin fusion protein combines apoptosis induction and angiogenesis inhibition to combat cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/